MENU

CDTX Cidara Therapeutics Forecast, Technical & Fundamental Analysis

a developer of drugs for fungal infection

Industry Biotechnology
CDTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
CDTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CDTX is expected to report earnings to fall 94.08% to -13 cents per share on August 08

Cidara Therapeutics CDTX Stock Earnings Reports
Q2'24
Est.
$-0.14
Q1'24
Missed
by $2.21
Q4'23
Missed
by $0.70
Q3'23
Beat
by $0.06
Q2'23
Missed
by $0.01
The last earnings report on May 15 showed earnings per share of -227 cents, missing the estimate of -7 cents. With 43.85K shares outstanding, the current market capitalization sits at 55.42M.
A.I. Advisor
published General Information

General Information

a developer of drugs for fungal infection

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
6310 Nancy Ridge Drive
Phone
+1 858 752-6170
Employees
73
Web
https://www.cidara.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCUP2.040.05
+2.51%
Ocuphire Pharma
DEO130.691.05
+0.81%
Diageo plc
STER15.650.11
+0.71%
Sterling Check Corp
GCI4.76-0.10
-2.06%
Gannett Co
BLCO15.53-0.64
-3.96%
Bausch + Lomb Corp

CDTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
+2.62%
BPTSY - CDTX
92%
Closely correlated
N/A
IVVD - CDTX
36%
Loosely correlated
-3.73%
CPRX - CDTX
35%
Loosely correlated
-0.80%
CABA - CDTX
33%
Poorly correlated
-2.32%
TRAW - CDTX
30%
Poorly correlated
-3.91%
More